Volume 386, Issue 9988, Pages 46-55 (July 2015) Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial The Lancet Volume 386, Issue 9988, Pages 46-55 (July 2015) DOI: 10.1016/S0140-6736(15)60690-0 Copyright © 2015 Bernhardt et al. Open Access article distributed under the terms of CC BY Terms and Conditions
Figure 1 Trial profile mRS=modified Rankin Scale. *More than one reason possible per patient. The Lancet 2015 386, 46-55DOI: (10.1016/S0140-6736(15)60690-0) Copyright © 2015 Bernhardt et al. Open Access article distributed under the terms of CC BY Terms and Conditions
Figure 2 Patients achieving each mRS score at 3 months mRS=modified Rankin Scale. The Lancet 2015 386, 46-55DOI: (10.1016/S0140-6736(15)60690-0) Copyright © 2015 Bernhardt et al. Open Access article distributed under the terms of CC BY Terms and Conditions
Figure 3 Time to walking unassisted 50 m by 3 months *Number of patients who had not achieved walking. The Lancet 2015 386, 46-55DOI: (10.1016/S0140-6736(15)60690-0) Copyright © 2015 Bernhardt et al. Open Access article distributed under the terms of CC BY Terms and Conditions
Figure 4 Prespecified subgroup analyses None of the individual subgroup analyses had significant treatment-by-subgroup interactions (all p>0·05). OR=odds ratio. rtPA=recombinant tissue plasminogen activator. The Lancet 2015 386, 46-55DOI: (10.1016/S0140-6736(15)60690-0) Copyright © 2015 Bernhardt et al. Open Access article distributed under the terms of CC BY Terms and Conditions